Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects
Vaikunthavasan Thiruchenthooran, Elena Sánchez‐López, Anna Gliszczyńska
Cancers (2023) Vol. 15, Iss. 2, pp. 475-475
Open Access | Times Cited: 22

Showing 22 citing articles:

A review of typical biological activities of glycyrrhetinic acid and its derivatives
Liang Chen, Jingwen Gong, Xu Yong, et al.
RSC Advances (2024) Vol. 14, Iss. 10, pp. 6557-6597
Open Access | Times Cited: 9
Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics
Sijongesonke Peter, Namhla Sotondoshe, Blessing A. Aderibigbe
Molecules (2024) Vol. 29, Iss. 10, pp. 2277-2277
Open Access | Times Cited: 9
Natural Alternatives in the Treatment of Colorectal Cancer: A Mechanisms Perspective
Karen Vanessa Fernandez-Muñoz, Ángel Sánchez‐Barrera, Marco Antonio Meraz‐Ríos, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 326-326
Open Access | Times Cited: 1
Management of pain in patients with bone metastases
Doudou Jing, Qian Zhao, Yibo Zhao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Combining Copper and Zinc into a Biosensor for Anti-Chemoresistance and Achieving Osteosarcoma Therapeutic Efficacy
Yan Yik Lim, Ahmad Mujahid Ahmad Zaidi, Azizi Miskon
Molecules (2023) Vol. 28, Iss. 7, pp. 2920-2920
Open Access | Times Cited: 18
Developing the Theory of Toxic Chemotherapeutic Nutrition for Cancer Cells and Targeting Tumors via Glucose Mutation: Medical Guidance and Integrated Therapeutic Approach
Maher M. Akl, Amr Ahmed
(2024)
Open Access | Times Cited: 4
Isolation, invitro, invivo anti-inflammatory, analgesic and antioxidant potential of Habenaria plantegania Lindl
Osama M. Alshehri, Madeeha Shabnam, Saeed Ahmed Asiri, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1353-1369
Closed Access | Times Cited: 4
Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
Rawaa AlChalabi, Raghda Makia, Semaa A. Shaban, et al.
Exploration of Immunology (2025)
Open Access
Exploring the antineoplastic potential of novel NSAID derivatives in combatting mammary tumorigenesis: a comprehensive review
Rashmi Dewangan, Nidhi Agrawal, Sanjay Kumar Lanjhiyana, et al.
Medicinal Chemistry Research (2025)
Closed Access
Ketorolac-Based Ester Derivatives as Promising Hits for Malignant Glioma: Synthesis, Brain Cancer Activity, Molecular Docking, Dynamic Simulation and DFT Investigation
Sami Ullah, Aftab Alam, Zainab Zainab, et al.
Journal of Molecular Structure (2024), pp. 141128-141128
Closed Access | Times Cited: 3
Benchmarking different docking protocols for predicting the binding poses of ligands complexed with cyclooxygenase enzymes and screening chemical libraries
Sara Shamsian, Babak Sokouti, Siavoush Dastmalchi
Bioimpacts (2023) Vol. 14, pp. 29955-29955
Open Access | Times Cited: 8
Cyclooxygenase and Cancer: Fundamental Molecular Investigations
Mauro Coluccia
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12342-12342
Open Access | Times Cited: 5
Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization
Shen Gao, Guojiang Wei, Qianwang Ma, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Indomethacin Derivatives as Potential Anticancer Agents ‐ Daybreak of New Epoch
Andjela Gogic, Marina Vesović, Nikola Nedeljković, et al.
ChemistrySelect (2024) Vol. 9, Iss. 30
Open Access | Times Cited: 1
Drug Repurposing for Cancer Treatment: A Comprehensive Review
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access | Times Cited: 1
Beneficial effects of fenoprofen on cognitive impairment induced by the kindling model of epilepsy: interaction of oxidative stress and inflammation
Maryam Rahimi‐Tesiye, Hassan Rajabi‐Maham, Abdolkarim Hosseini, et al.
Brain Research Bulletin (2024) Vol. 220, pp. 111151-111151
Open Access | Times Cited: 1
Nebenwirkungen von NSAR im Gastrointestinaltrakt
Michael A. Überall, Anton Gillessen
Schmerzmedizin (2024) Vol. 40, Iss. 4, pp. 16-22
Closed Access
In Silico Studies of a Novel Scaffold of Acetylsalicylic Acid Derivatives Against EGFR by Molecular Docking and Molecular Dynamics Simulations
Alpaslan Bayrakdar
Cumhuriyet Science Journal (2024) Vol. 45, Iss. 2, pp. 274-281
Open Access
Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review)
Ganghui Ye, Meng Ye, Xin Jin
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4113-4171
Closed Access
Optogenetic screening of MCT1 activity implicates a cluster of non-steroidal anti-inflammatory drugs (NSAIDs) as inhibitors of lactate transport
Scott A. Wegner, Hahn Kim, José L. Avalos‬
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0312492-e0312492
Open Access
Combining Copper and Zinc into a Biosensor for Anti-Chemoresistance and Achieving Osteosarcoma Therapeutic Efficacy
Yan Yik Lim, Ahmad Mujahid Ahmad Zaidi, Azizi Miskon
(2023)
Open Access | Times Cited: 1
Synthesis and Preliminary Screening of the Biological Activity of Sulindac Sulfoximine Derivatives
Cosimo Cardellicchio, Valentino Laquintana, Rosa Maria Iacobazzi, et al.
Applied Sciences (2023) Vol. 13, Iss. 21, pp. 12002-12002
Open Access
Page 1

Scroll to top